OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.08
+7.17%Aug 10, 2026, 22:56 UTC
Orchestra BioMed Holdings, Inc. reported a second-quarter loss of $0.38 per share, missing the Zacks Consensus Estimate of a loss of $0.35.
Source: